melan-a analog peptide
Vaccineexperimental
Clinical trial activity
5 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 1999 (NCT00112216)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- melan-a analog peptide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00559026 | Phase 1 | Sep 1, 2004 | ISTITUTO REGINA ELENA, Istituto Superiore di Sanità, University of Rome Tor Vergata |
| NCT00160992 | Phase 1 | Jul 1, 2004 | Barletta Foundation, Fond'action contre le cancer, National Center of Competence in Resaerch, Switzerland, University of Lausanne |
| NCT00112242 | Phase 1 | Feb 1, 2004 | Ludwig Institute for Cancer Research, University of Lausanne |
| NCT00112229 | Phase 1 | Apr 1, 2003 | Ludwig Institute for Cancer Research, University of Lausanne |
| NCT00112216 | Phase 1 | May 1, 1999 | Ludwig Institute for Cancer Research, University of Lausanne |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Lausanne | Academic/Hospital | 4 | 4 | 1 | 1999 |
| Ludwig Institute for Cancer Research | Academic/Hospital | 3 | 0 | 1 | 1999 |
| Barletta Foundation | Academic/Hospital | 1 | 0 | 1 | 2004 |
| Fond'action contre le cancer | Academic/Hospital | 1 | 0 | 1 | 2004 |
| ISTITUTO REGINA ELENA | Academic/Hospital | 1 | 0 | 1 | 2004 |
| Istituto Superiore di Sanità | Academic/Hospital | 1 | 1 | 1 | 2004 |
| National Center of Competence in Resaerch, Switzerland | Government | 1 | 0 | 1 | 2004 |
| University of Rome Tor Vergata | Academic/Hospital | 1 | 0 | 1 | 2004 |
8 organizations
Page 1 / 1